DLG4 (Disks large homolog 4) variants and mutations
DLG4 (also known as Disks large homolog 4) is a human protein-coding gene encoding a disks large homolog 4 protein. It organizes glutamate receptors, signaling enzymes, and cytoskeletal proteins at excitatory postsynaptic densities, making it central to synaptic transmission and plasticity. Haploinsufficiency can cause a neurodevelopmental disorder with intellectual disability, autism-related features, and sometimes epilepsy. This analysis covers 892 DLG4 variants and mutations. Of these, 70% have computational variant effect predictions. Disease context includes intellectual developmental disorder 62, hereditary disease, and neurodegenerative disease. Example DLG4 variants include M1?, C3S, and V7L.
Variant analysis overview
- Gene: DLG4
- Protein: Disks large homolog 4
- UniProt accession: P78352
- Organism: Homo sapiens
- Variants analyzed: 892
- Variant scope: all variants
- Completed: 2026-08-20
Variant and mutation evidence
- Variant composition: 664 unspecified-consequence records; 64 synonymous variants; 139 missense variants; 4 stop-gained variants; 1 in-frame deletions; 3 splice-region variants; 8 frameshift variants; 9 substitution
- Prediction scores: 628 variants have prediction scores (70% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: intellectual developmental disorder 62, hereditary disease, neurodegenerative disease, Intellectual disability, complex neurodevelopmental disorder, Neurodevelopmental delay, Disproportionate tall stature, autoimmune disorder of central nervous system, marfanoid habitus and intellectual disability, intellectual developmental disorder with paroxysmal dyskinesia or seizures, autism spectrum disorder, intellectual disability-epilepsy-extrapyramidal syndrome.
Protein structure and variant hotspots
- Protein features: 5 domains; 15 post-translational modification sites.
- Structural context: 629 variants have structural context.
- PTM context: 20 variants overlap post-translational modification sites.
- Experimental data: 90 protein positions have experimental scores. Source: DLG4 PDZ domain domainome 1.0.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable DLG4 variants
Examples include M1?, C3S, V7L, T9N, Y12C, R13C, R13Q, Y14S. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, cosmic curated COSV57238
- C3S (p.Cys3Ser), gnomAD rs1401805036, REVEL 0.20, CADD 20.10
- V7L (p.Val7Leu), TOPMed rs2070954028, gnomAD rs2070954028, REVEL 0.09, CADD 20.20
- T9N (p.Thr9Asn), rs2508170756, ClinGen CA397721172, ClinVar RCV002644724, REVEL 0.11, CADD 20.30, Uncertain significance, Inborn genetic diseases
- Y12C (p.Tyr12Cys), cosmic curated COSV57236, REVEL 0.54, CADD 25.00
- R13C (p.Arg13Cys), cosmic curated COSV10513, Ensembl rs2070567513, REVEL 0.27, CADD 32.00
- R13Q (p.Arg13Gln), rs867202919, []
- Y14S (p.Tyr14Ser), ExAC rs767412117, TOPMed rs767412117, gnomAD rs767412117, REVEL 0.25, CADD 23.60
- Q15K (p.Gln15Lys), cosmic curated COSV57240, REVEL 0.17, CADD 23.10
- D16H (p.Asp16His), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10026, Variant assessed as somatic; moderate impact.
- E17* (p.Glu17Ter), cosmic curated COSV10513, CADD 46.00
- D18A (p.Asp18Ala), ExAC rs763066158, TOPMed rs763066158, gnomAD rs763066158, REVEL 0.19, CADD 23.40
- D18G (p.Asp18Gly), NCI-TCGA TCGA novel, ExAC rs763066158, TOPMed rs763066158, gnomAD rs763066158, REVEL 0.19, CADD 23.90, Variant assessed as somatic; moderate impact.
- T19A (p.Thr19Ala), cosmic curated COSV10731, REVEL 0.07, CADD 20.90
- T19M (p.Thr19Met), cosmic curated COSV57240, ExAC rs750562912, TOPMed rs750562912, gnomAD rs750562912, REVEL 0.13, CADD 25.30
- P21L (p.Pro21Leu), cosmic curated COSV57240, REVEL 0.25, CADD 24.10
- P21S (p.Pro21Ser), cosmic curated COSV10513, TOPMed rs2070566957, REVEL 0.24, CADD 22.50
- P21T (p.Pro21Thr), cosmic curated COSV10513, REVEL 0.29, CADD 23.50
- H24Q (p.His24Gln), NCI-TCGA Cosmic COSV5723, cosmic curated COSV57237, Variant assessed as somatic; moderate impact.
- S25R (p.Ser25Arg), cosmic curated COSV57236
- S25T (p.Ser25Thr), TOPMed rs2070566580, REVEL 0.06, CADD 22.10
- S25C (p.Ser25Cys), rs993284019, []
- P26L (p.Pro26Leu), cosmic curated COSV57236, REVEL 0.07, CADD 23.10, Uncertain significance, Inborn genetic diseases
- N31S (p.Asn31Ser), TOPMed rs1230103178, gnomAD rs1230103178, REVEL 0.08, CADD 21.50, Uncertain significance, Inborn genetic diseases
- Q32* (p.Gln32Ter), rs2508083151, ClinGen CA397720927, ClinVar RCV003219143, CADD 44.00, Pathogenic
- A33D (p.Ala33Asp), Ensembl rs2070334573, REVEL 0.28, CADD 25.00
- A33S (p.Ala33Ser), ExAC rs768555832, gnomAD rs768555832, REVEL 0.22, CADD 24.50
- N34S (p.Asn34Ser), ExAC rs746846985, TOPMed rs746846985, gnomAD rs746846985, REVEL 0.04, CADD 18.20
- S35F (p.Ser35Phe), Ensembl rs2070334076, REVEL 0.23, CADD 24.90
- P36A (p.Pro36Ala), Ensembl rs757521934
- P37A (p.Pro37Ala), ExAC rs758437498, gnomAD rs758437498, REVEL 0.38, CADD 23.30
- P37L (p.Pro37Leu), cosmic curated COSV10513
- P37S (p.Pro37Ser), ExAC rs758437498, gnomAD rs758437498, REVEL 0.32, CADD 23.60
- P37T (p.Pro37Thr), ExAC rs758437498, gnomAD rs758437498, REVEL 0.33, CADD 23.50
- I39T (p.Ile39Thr), TOPMed rs1425387906, gnomAD rs1425387906, REVEL 0.19, CADD 22.70
- I39V (p.Ile39Val), TOPMed rs1457784229, gnomAD rs1457784229, REVEL 0.11, CADD 17.40
- V40I (p.Val40Ile), TOPMed rs2070332539
- D43N (p.Asp43Asn), Ensembl rs2142889058, CADD 25.30
- D43Y (p.Asp43Tyr), NCI-TCGA Cosmic COSV5723, cosmic curated COSV57236, REVEL 0.43, CADD 24.20, Variant assessed as somatic; moderate impact.
- T44I (p.Thr44Ile), gnomAD rs1161910829, REVEL 0.09, CADD 22.50
- E46D (p.Glu46Asp), NCI-TCGA Cosmic COSV5723, cosmic curated COSV57237, CADD 21.50, Variant assessed as somatic; moderate impact.
- G49E (p.Gly49Glu), rs756296025, ExAC rs756296025, gnomAD rs756296025, REVEL 0.12, CADD 21.90, Variant assessed as somatic; moderate impact.
- Y50F (p.Tyr50Phe), ExAC rs754400138, TOPMed rs754400138, gnomAD rs754400138, REVEL 0.21, CADD 23.80
- L52F (p.Leu52Phe), Ensembl rs1567542317, REVEL 0.05, CADD 19.40
- Q53H (p.Gln53His), cosmic curated COSV10026
- V54G (p.Val54Gly), Ensembl rs1597473660
- V54M (p.Val54Met), TOPMed rs1287207876, gnomAD rs1287207876, REVEL 0.26, CADD 22.20
- N55K (p.Asn55Lys), ESP rs377743557, TOPMed rs377743557, gnomAD rs377743557
- G56R (p.Gly56Arg), NCI-TCGA Cosmic COSV1002, NCI-TCGA Cosmic COSV5723, cosmic curated COSV57237, REVEL 0.85, CADD 27.40, Variant assessed as somatic; moderate impact.
- G56W (p.Gly56Trp), cosmic curated COSV10026, REVEL 0.84, CADD 28.30
- T57I (p.Thr57Ile), rs200154740, ClinGen CA8337270, ClinVar RCV002985921, ClinVar RCV003427646, REVEL 0.16, CADD 22.60, Likely benign, not provided; Inborn genetic diseases
- E58D (p.Glu58Asp), ExAC rs745800686, TOPMed rs745800686, gnomAD rs745800686, REVEL 0.22, CADD 15.10
- E58K (p.Glu58Lys), TOPMed rs1482807963
- G59E (p.Gly59Glu), TOPMed rs1253688873, gnomAD rs1253688873, REVEL 0.16, CADD 22.60
- E60D (p.Glu60Asp), TOPMed rs1451040768, gnomAD rs1451040768, REVEL 0.22, CADD 13.00
- M61T (p.Met61Thr), gnomAD rs1304712290, Uncertain significance, Inborn genetic diseases
- E64K (p.Glu64Lys), NCI-TCGA TCGA novel, REVEL 0.39, CADD 27.80, Variant assessed as somatic; moderate impact.
- E65* (p.Glu65Ter), rs2142888007, ClinGen CA397720239, ClinVar RCV001800186, ClinVar RCV002541336, Pathogenic
- E65K (p.Glu65Lys), cosmic curated COSV57238
- T67I (p.Thr67Ile), rs2142888003, ClinGen CA397720221, ClinVar RCV001760877, Ensembl rs2142888003, AlphaMissense 0.45, MetaLR 0.11, Uncertain significance, not provided
- L68S (p.Leu68Ser), cosmic curated COSV10026
- R70K (p.Arg70Lys), rs2508034347, ClinGen CA397720203, ClinVar RCV003408313, REVEL 0.22, CADD 24.70, Uncertain significance, DLG4-related disorder
- S73* (p.Ser73Ter), rs2142886687, ClinGen CA397720169, ClinVar RCV001800188, Ensembl rs2142886687, Pathogenic
- A80T (p.Ala80Thr), NCI-TCGA Cosmic COSV5723, cosmic curated COSV57238, Variant assessed as somatic; moderate impact.
- G81C (p.Gly81Cys), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10026, Variant assessed as somatic; moderate impact.
- G81F (p.Gly81Phe), cosmic curated COSV57242
- G81S (p.Gly81Ser), Ensembl rs12452520
- G81V (p.Gly81Val), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10026, Variant assessed as somatic; moderate impact.
- N85Y (p.Asn85Tyr), rs2508029658, ClinGen CA397720093, ClinVar RCV003156527, Uncertain significance, not provided
- P86T (p.Pro86Thr), ExAC rs753336687, TOPMed rs753336687, gnomAD rs753336687, REVEL 0.33, CADD 26.10
- I88V (p.Ile88Val), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10026, REVEL 0.08, CADD 18.30, Variant assessed as somatic; moderate impact.
- G89S (p.Gly89Ser), rs868786374, NCI-TCGA Cosmic COSV5724, cosmic curated COSV57242, TOPMed rs868786374, REVEL 0.09, CADD 23.50, Variant assessed as somatic; moderate impact.
- G89V (p.Gly89Val), cosmic curated COSV10814
- D90E (p.Asp90Glu), rs755756114, ClinGen CA397720055, ClinVar RCV003235983, ExAC rs755756114, REVEL 0.05, CADD 22.70, Uncertain significance, not provided
- D91A (p.Asp91Ala), Ensembl rs1597472480
- D91N (p.Asp91Asn), NCI-TCGA Cosmic COSV5723, cosmic curated COSV57238, REVEL 0.35, CADD 26.90, Variant assessed as somatic; moderate impact.
- P92L (p.Pro92Leu), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10026, Variant assessed as somatic; moderate impact.
- P92S (p.Pro92Ser), NCI-TCGA Cosmic COSV5723, cosmic curated COSV57236, REVEL 0.20, CADD 23.80, Variant assessed as somatic; moderate impact.
- S93F (p.Ser93Phe), NCI-TCGA Cosmic COSV5723, cosmic curated COSV57239, Variant assessed as somatic; moderate impact.
- F95I (p.Phe95Ile), gnomAD rs1387663370, REVEL 0.29, CADD 27.80
- K98N (p.Lys98Asn), NCI-TCGA Cosmic COSV5724, cosmic curated COSV57240, REVEL 0.20, CADD 24.10, Variant assessed as somatic; moderate impact.
- A104S (p.Ala104Ser), NCI-TCGA Cosmic COSV5723, cosmic curated COSV57236, Variant assessed as somatic; moderate impact.
- A105V (p.Ala105Val), cosmic curated COSV57236, REVEL 0.48, CADD 28.00, Uncertain significance, not provided
- Q107* (p.Gln107Ter), rs2142886433, ClinGen CA397719902, ClinVar RCV001800190, Ensembl rs2142886433, Pathogenic
- Q107R (p.Gln107Arg), rs767252131, ClinGen CA8337233, ClinVar RCV002673401, ExAC rs767252131, REVEL 0.15, CADD 24.10, Uncertain significance, Inborn genetic diseases
- R110C (p.Arg110Cys), NCI-TCGA Cosmic COSV5723, cosmic curated COSV57239, REVEL 0.40, CADD 29.30, Variant assessed as somatic; moderate impact.
- R110G (p.Arg110Gly), cosmic curated COSV10513
- L111=, NCI-TCGA Cosmic COSV5723, Variant assessed as somatic; low impact.
- R112S (p.Arg112Ser), cosmic curated COSV57237
- N114D (p.Asn114Asp), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10026, Variant assessed as somatic; moderate impact.
- N114S (p.Asn114Ser), rs2508026074, ClinGen CA397719771, ClinVar RCV002702522, REVEL 0.24, CADD 24.10, Uncertain significance, Inborn genetic diseases
- D115N (p.Asp115Asn), rs754682597, cosmic curated COSV10814, ExAC rs754682597, gnomAD rs754682597, REVEL 0.76, CADD 28.50, Variant assessed as somatic; moderate impact.
- S116I (p.Ser116Ile), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10026, Variant assessed as somatic; moderate impact.
- S116N (p.Ser116Asn), rs751255727, ClinGen CA8337210, ClinVar RCV004376103, ExAC rs751255727, REVEL 0.10, CADD 23.60, Uncertain significance, Inborn genetic diseases
- L118V (p.Leu118Val), rs762793313, ClinGen CA397719720, ClinVar RCV002472178, Uncertain significance, Intellectual developmental disorder 62
- V123M (p.Val123Met), Ensembl rs2070279366
- D124G (p.Asp124Gly), rs794727772, Uncertain significance
- V125L (p.Val125Leu), 1000Genomes rs571720664, ExAC rs571720664, TOPMed rs571720664, gnomAD rs571720664, Uncertain significance
- V125M (p.Val125Met), rs571720664, ClinGen CA8337206, cosmic curated COSV10646, ClinVar RCV002462675, REVEL 0.34, CADD 25.30, Uncertain significance, not provided
- R126C (p.Arg126Cys), gnomAD rs1453612541, REVEL 0.23, CADD 24.90
- R126H (p.Arg126His), cosmic curated COSV10026, ExAC rs760702915, TOPMed rs760702915, gnomAD rs760702915, REVEL 0.13, CADD 31.00
- E127* (p.Glu127Ter), cosmic curated COSV57238
- E127D (p.Glu127Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- E127K (p.Glu127Lys), rs928035071, ClinVar RCV004592135, gnomAD rs928035071, REVEL 0.19, CADD 23.60, Uncertain significance, not provided
- H130R (p.His130Arg), rs958166043, []
- A132V (p.Ala132Val), ExAC rs772124078, TOPMed rs772124078, gnomAD rs772124078, REVEL 0.08, CADD 15.70
- A133E (p.Ala133Glu), rs982251458, ClinGen CA397719515, ClinVar RCV003219144, AlphaMissense 0.99, MetaLR 0.09, Uncertain significance, Intellectual developmental disorder 62
- A133V (p.Ala133Val), rs982251458, ClinGen CA287420945, ClinVar RCV003886732, Ensembl rs982251458, REVEL 0.33, AlphaMissense 0.99, Uncertain significance, not provided
- V134G (p.Val134Gly), ExAC rs749722834, gnomAD rs749722834, REVEL 0.68, CADD 26.90
- E135* (p.Glu135Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- A136S (p.Ala136Ser), cosmic curated COSV57236
- A136T (p.Ala136Thr), ExAC rs778396489, gnomAD rs778396489, REVEL 0.33, CADD 25.50
- L137I (p.Leu137Ile), cosmic curated COSV57240
- L137P (p.Leu137Pro), rs796051908, Conflicting interpretations
- E139* (p.Glu139Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- E139D (p.Glu139Asp), rs2508024885, ClinGen CA397719430, ClinVar RCV003237073, Uncertain significance, not provided
- G141D (p.Gly141Asp), cosmic curated COSV57240
- S142A (p.Ser142Ala), ExAC rs770457221, gnomAD rs770457221, REVEL 0.06, CADD 20.90
- S142F (p.Ser142Phe), cosmic curated COSV10513
- V144I (p.Val144Ile), 1000Genomes rs200429432, ExAC rs200429432, gnomAD rs200429432, REVEL 0.14, CADD 25.10
- R145C (p.Arg145Cys), cosmic curated COSV57238
- R145H (p.Arg145His), rs1334906542, cosmic curated COSV10459, TOPMed rs1334906542, gnomAD rs1334906542, REVEL 0.16, CADD 24.50, Variant assessed as somatic; moderate impact.
- L146P (p.Leu146Pro), Ensembl rs2070273147
- Y147C (p.Tyr147Cys), NCI-TCGA TCGA novel, Ensembl rs2070272854, REVEL 0.26, CADD 24.90, Variant assessed as somatic; moderate impact.
- V148I (p.Val148Ile), gnomAD rs1373830825, REVEL 0.07, CADD 22.90
- R150C (p.Arg150Cys), cosmic curated COSV57238, REVEL 0.46, CADD 29.20
- R150H (p.Arg150His), rs754521971, NCI-TCGA Cosmic COSV1002, cosmic curated COSV10026, ExAC rs754521971, REVEL 0.47, CADD 27.60, Variant assessed as somatic; moderate impact.
- R150L (p.Arg150Leu), ExAC rs754521971, TOPMed rs754521971, gnomAD rs754521971
- R151Q (p.Arg151Gln), Ensembl rs1428213359, REVEL 0.19, CADD 26.80
- R151W (p.Arg151Trp), rs2508024417, ClinVar RCV004594937, REVEL 0.26, CADD 28.30, Uncertain significance, Intellectual developmental disorder 62
- P153S (p.Pro153Ser), TOPMed rs1281272482, REVEL 0.09, CADD 23.60
- P154L (p.Pro154Leu), ExAC rs779621148, TOPMed rs779621148, gnomAD rs779621148, REVEL 0.08, CADD 19.90
- A155V (p.Ala155Val), rs2142885359, ClinGen CA397719222, ClinVar RCV001797458, Ensembl rs2142885359, AlphaMissense 0.08, MetaLR 0.05, Uncertain significance, not provided
- K157N (p.Lys157Asn), Ensembl rs2142885342
- V158F (p.Val158Phe), TOPMed rs1484512483, REVEL 0.10, CADD 22.20, Uncertain significance
- V158I (p.Val158Ile), rs1484512483, ClinGen CA397719189, ClinVar RCV002280027, TOPMed rs1484512483, REVEL 0.05, CADD 12.20, Uncertain significance, not provided
- V158L (p.Val158Leu), TOPMed rs1484512483, REVEL 0.04, CADD 16.00, Uncertain significance
- M159T (p.Met159Thr), cosmic curated COSV57237, gnomAD rs1468527368, REVEL 0.04, CADD 19.50
- E160* (p.Glu160Ter), rs2142885279, ClinGen CA397719155, ClinVar RCV001800192, Ensembl rs2142885279, Pathogenic
- E160D (p.Glu160Asp), rs750247768, ClinGen CA8337189, cosmic curated COSV57236, ClinVar RCV003489662, REVEL 0.15, CADD 21.00, Uncertain significance, Inborn genetic diseases; not specified
- I161L (p.Ile161Leu), TOPMed rs2070270144, REVEL 0.06, CADD 21.10
- K162T (p.Lys162Thr), NCI-TCGA TCGA novel, Uncertain significance, not provided
- K165Q (p.Lys165Gln), cosmic curated COSV57241
- G169A (p.Gly169Ala), Ensembl rs2142884582
- G169C (p.Gly169Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G169D (p.Gly169Asp), NCI-TCGA TCGA novel, REVEL 0.33, CADD 25.20, Variant assessed as somatic; moderate impact.
- L170F (p.Leu170Phe), ESP rs370979313, gnomAD rs370979313
- L170I (p.Leu170Ile), ESP rs370979313, gnomAD rs370979313
- L170P (p.Leu170Pro), Ensembl rs2142884544
- F172V (p.Phe172Val), TOPMed rs2070259040
- S173N (p.Ser173Asn), cosmic curated COSV10588, REVEL 0.18, CADD 24.30
- I174F (p.Ile174Phe), cosmic curated COSV10731
- A175S (p.Ala175Ser), TOPMed rs1179126590, gnomAD rs1179126590, REVEL 0.20, CADD 24.30
- A175T (p.Ala175Thr), NCI-TCGA Cosmic COSV5724, cosmic curated COSV57242, REVEL 0.29, CADD 24.80, Variant assessed as somatic; moderate impact.
- G176A (p.Gly176Ala), rs2508020430, ClinGen CA397719003, ClinVar RCV003574299, Uncertain significance, not provided
- G176R (p.Gly176Arg), rs758066384, ExAC rs758066384, gnomAD rs758066384, REVEL 0.52, CADD 26.30, Variant assessed as somatic; moderate impact.
- G177V (p.Gly177Val), rs2142884433, ClinGen CA397718996, ClinVar RCV001754561, Ensembl rs2142884433, REVEL 0.61, CADD 25.40, Pathogenic/Likely pathogenic, Intellectual developmental disorder 62
- V178I (p.Val178Ile), ExAC rs778679470, TOPMed rs778679470, gnomAD rs778679470, REVEL 0.07, CADD 21.50, Uncertain significance, Intellectual developmental disorder 62
- V178L (p.Val178Leu), ExAC rs778679470, TOPMed rs778679470, gnomAD rs778679470, REVEL 0.03, CADD 23.80
- G179E (p.Gly179Glu), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10026, REVEL 0.33, CADD 25.70, Variant assessed as somatic; moderate impact.
- I183L (p.Ile183Leu), Ensembl rs2142884358
- I183M (p.Ile183Met), Ensembl rs1567540969, REVEL 0.18, CADD 23.00
- P184Q (p.Pro184Gln), cosmic curated COSV10026
- P184S (p.Pro184Ser), Ensembl rs2142884331
- G185* (p.Gly185Ter), cosmic curated COSV10026
- G185R (p.Gly185Arg), ExAC rs759632708, REVEL 0.53, CADD 27.00
- D186V (p.Asp186Val), rs2142884288, ClinGen CA397718940, ClinVar RCV001800194, Ensembl rs2142884288, AlphaMissense 1.00, MetaLR 0.32, Pathogenic/Likely pathogenic, Intellectual developmental disorder 62
- N187S (p.Asn187Ser), TOPMed rs2070254480, gnomAD rs2070254480, REVEL 0.31, CADD 25.50
- S188I (p.Ser188Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Y190C (p.Tyr190Cys), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10026, gnomAD rs2070253586, REVEL 0.70, CADD 28.70, Variant assessed as somatic; moderate impact.
- V191I (p.Val191Ile), NCI-TCGA TCGA novel, REVEL 0.11, CADD 22.90, Variant assessed as somatic; moderate impact.
- T192R (p.Thr192Arg), Ensembl rs1567540933, REVEL 0.36, CADD 27.10
- E196D (p.Glu196Asp), TOPMed rs2070252417, gnomAD rs2070252417, REVEL 0.08, CADD 22.70
- E196K (p.Glu196Lys), NCI-TCGA Cosmic COSV5724, cosmic curated COSV57240, REVEL 0.34, CADD 28.00, Variant assessed as somatic; moderate impact.
- G197A (p.Gly197Ala), TOPMed rs1344403587, gnomAD rs1344403587, REVEL 0.48, CADD 25.10
- G197E (p.Gly197Glu), NCI-TCGA Cosmic COSV5724, cosmic curated COSV57242, TOPMed rs1344403587, gnomAD rs1344403587, REVEL 0.45, CADD 25.80, Variant assessed as somatic; moderate impact.
- G198A (p.Gly198Ala), cosmic curated COSV10026
- G198R (p.Gly198Arg), gnomAD rs1326420629, REVEL 0.68, CADD 26.30, Uncertain significance
- G198S (p.Gly198Ser), rs1326420629, ClinGen CA397718856, ClinVar RCV001800195, gnomAD rs1326420629, REVEL 0.41, CADD 26.10, Uncertain significance, Intellectual developmental disorder 62
- G198V (p.Gly198Val), rs2508019023, ClinGen CA397718851, ClinVar RCV003219148, Uncertain significance, Intellectual developmental disorder 62
Public DLG4 analysis runs
- DLG4 analysis run — DLG4 (892 variants) — completed 2026-08-20